-- This triggers the users table's own RLS policies, which may in turn -- query other tables, causing policy-chain recursion until Postgres -- hits the stack depth limit. -- Fix: Wrap the admin check ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...

CEO expectations for AI-driven growth remain high in 2026—at the same time their workforces are grappling with the more sober reality of current AI performance. Gartner research finds that only one in ...

How must databases adapt to generative AI, and how should databases be integrated with large language models (LLMs)? These are questions that Sailesh Krishnamurthy has grappled with for several years ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

With the official release of Microsoft's latest database offering, let's see what was improved and what still needs some work. Today, at Ignite, Microsoft announced the general availability of SQL ...

In most enterprises, data access still feels like a locked room with SQL as the only key. Business teams depend on data engineers for every report, dashboard, or metric tweak. Even in the age of ...

As SQL development increasingly becomes part of full-stack workflows, developers are looking for ways to simplify their tooling without compromising capability. While SQL Server Management Studio ...

Recursion Pharmaceuticals (RXRX) closed at $4.77 in the latest trading session, marking a -1.24% move from the prior day. This change lagged the S&P 500's 0.47% gain on the day. Meanwhile, the Dow ...